CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | BOLNO PAUL President and CEO | Grant or award | +150,000 | 422,181 | ||
| 2021-02-01 | BOLNO PAUL President and CEO | Grant or award · Share Option (right to buy) | +200,000 | 200,000 | ||
| 2021-02-01 | Panzara Michael A. | Grant or award | +50,000 | 89,349 | ||
| 2021-02-01 | Panzara Michael A. | Grant or award · Share Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-01 | Vargeese Chandra Chief Technology Officer | Grant or award | +50,000 | 88,557 | ||
| 2021-02-01 | Vargeese Chandra Chief Technology Officer | Grant or award · Share Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-01 | Moran Kyle Chief Financial Officer | Grant or award | +50,000 | 71,584 | ||
| 2021-02-01 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) | +50,000 | 50,000 | ||
| 2020-09-15 | BOLNO PAUL President and CEO | Exercise or conversion | +100,000 | $2.48 | $248K | 372,181 |
| 2020-09-15 | BOLNO PAUL President and CEO | Sale | −100,000 | $15.00 | $1.5M | 272,181 |
| 2020-09-15 | BOLNO PAUL President and CEO | Exercise or conversion · Share Option (right to buy) | −100,000 | 97,778 | ||
| 2020-08-25 | BOLNO PAUL President and CEO | Exercise or conversion | +25,000 | $2.48 | $62K | 297,181 |
| 2020-08-25 | BOLNO PAUL President and CEO | Sale | −25,000 | $12.00 | $300K | 272,181 |
| 2020-08-25 | BOLNO PAUL President and CEO | Exercise or conversion · Share Option (right to buy) | −25,000 | 197,778 | ||
| 2020-08-18 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | Kolchinsky Peter Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 | ||
| 2020-08-18 | Pott Amy Director | Grant or award · Share Option (right to buy) | +10,500 | 10,500 |
Page 16 of 22 · 433 trades